The biotech industry thrived during the pandemic by introducing vaccines and antivirals, registering substantial revenue growth. Moreover, the active development of therapeutics and other medications to treat increasing chronic diseases and investment in innovative technologies are creating lucrative growth opportunities for this sector.
The biotechnology market is expected to surpass around $1.68 trillion by 2030, expanding at a CAGR of 8.7% from 2021 to 2030.
